Pump design could give new hope to heart patients

Apr 12, 2007

A new counter-flow heart pump being developed by Queensland University of Technology has the potential to revolutionise future designs of the mechanical heart. Lead researcher Associate Professor Andy Tan said the heart pump's innovative design was based on a doubleoutput centrifugal model that pushed the blood in a counter direction to ensure correct flow through both sides of the heart, and is the subject of a patent application.

"The counter-flow pump is a bi-ventricular assist device (BVAD), meaning it supports both the left and right sides of the heart simultaneously," he said. "But what's so groundbreaking is that it is the first device to combine the function of two pumps into one unit. Professor Tan said current double heart pump technology was too bulky because it required the implant of two pumps that worked independently.

"The problem with two pumps is that it requires different controllers and can potentially lead to an uneven blood flow.

"The concept of the counter-flow pump is that it has two independent impellers to simulate two pumps to augment the operations of the left and right ventricles but is essential only one. "Using independent impellers, the blood is able to flow at a higher delivery pressure as required by the left chamber of the heart, and a slower pressure as required by the right chamber of the heart."

Professor Tan said a shortage of heart donors and high rates of cardiovascular disease were driving scientists across the globe to develop the technology for a replacement heart. "Each year in Australia, 44 per cent of all deaths are related to heart disease," Professor Tan said. "In fact heart failure, stroke and vascular disease kill more Australians than any other disease group. To reduce the number of deaths, treatment is now focused on medical devices that can assist or totally replicate the function of the heart."

He said a heart pump capable of supporting both chambers would dramatically increase patients' chance of survival. "Clinical studies around the world have found that patients who received a permanent left heart pump (left ventricular assist device) reduced their risk of dying within one year by 47 per cent," Professor Tan said. "Unfortunately 25 per cent of these patients went on to develop right heart failure syndrome, infection and multiorgan failure. We have developed the design, and computer modelling has shown that it works."

Source: Queensland University of Technology

Explore further: A better way to track emerging cell therapies using MRIs

add to favorites email to friend print save as pdf

Related Stories

Team improves solar-cell efficiency

8 hours ago

New light has been shed on solar power generation using devices made with polymers, thanks to a collaboration between scientists in the University of Chicago's chemistry department, the Institute for Molecular ...

Calif. teachers fund to boost clean energy bets

8 hours ago

The California State Teachers' Retirement System says it plans to increase its investments in clean energy and technology to $3.7 billion, from $1.4 billion, over the next five years.

Alibaba surges in Wall Street debut

8 hours ago

A buying frenzy sent Alibaba shares sharply higher Friday as the Chinese online giant made its historic Wall Street trading debut.

Dwindling wind may tip predator-prey balance

8 hours ago

Bent and tossed by the wind, a field of soybean plants presents a challenge for an Asian lady beetle on the hunt for aphids. But what if the air—and the soybeans—were still?

Recommended for you

A better way to track emerging cell therapies using MRIs

17 hours ago

Cellular therapeutics – using intact cells to treat and cure disease – is a hugely promising new approach in medicine but it is hindered by the inability of doctors and scientists to effectively track the movements, destination ...

User comments : 0